The department of veterans affairs biorepository brain bank: A national resource for amyotrophic lateral sclerosis research

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Volumn 14, Issue 7-8, 2013, Pages 591-597

  Brady, Christopher B ^a,d,f   Trevor, Katrina T ^g,h   Stein, Thor D ^b,e   Deykin, Eva Y ^a   Perkins, Sally D ^a   Averill, James G ^g   Guilderson, Latease ^a   McKee, Ann C ^a,b,e   Renner, Stephen W ^g,h   Kowall, Neil W ^a,c,e  

^a Hoechst Marion Roussel   (United States)

^b Departments of Pathology   (United States)

^c VA BOSTON HEALTHCARE SYSTEM   (United States)

^d Departments of Neurology   (Australia)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

^h UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Amyotrophic lateral sclerosis; Brain banking; Neuropathology; Prognostic; Survival; Tissue banking

Indexed keywords

AGED; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; AMYOTROPHIC LATERAL SCLEROSIS FUNCTIONAL RATING SCALE REVISED; ARTICLE; AUTOPSY; BRAIN DISEASE; CHRONIC TRAUMATIC ENCEPHALOPATHY; CONTROLLED STUDY; DEPARTMENT OF VETERANS AFFAIRS BIOREPOSITORY BRAIN BANK; DIFFUSE LEWY BODY DISEASE; DISEASE COURSE; DISEASE DURATION; ENVIRONMENTAL FACTOR; FEMALE; FOLLOW UP; FRONTOTEMPORAL DEMENTIA; FROZEN SECTION; GENETIC RISK; GOVERNMENT; HEALTH CARE FACILITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MOTOR NEURON DISEASE; NEUROPATHOLOGY; PRIORITY JOURNAL; RATING SCALE; TISSUE FIXATION; TRAUMATIC BRAIN INJURY;

ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; BIOMEDICAL RESEARCH; BRAIN; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; TISSUE BANKS; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; VETERANS; YOUNG ADULT;

EID: 84887437762     PISSN: 21678421     EISSN: 21679223     Source Type: Journal    
DOI: 10.3109/21678421.2013.822516     Document Type: Article

References (41)

1. Committee on the Review of the Scientifi c Literature on Amyotrophic Lateral Sclerosis in Veterans. Amyotrophic Lateral Sclerosis in Veterans: Review of the Scientifi c Literature. Washington, D.C.: Institute of Medicine of the National Academies, 2006.
2. Haley R W. E xcess incidence of ALS in young Gulf War veterans. Neurology. 2003; 61:750-6. Epub 2003/09/25.
3. Horner RD, Kamins KG, Feussner JR, Grambow SC, Hoff-Lindquist J, Harati Y, et al. Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology. 2003; 61:742-9. Epub 2003/09/25.
4. Allen KD, Kasarskis EJ, Bedlack RS, Rozear MP, Morgenlander JC, Sabet A, et al. The National Registry of Veterans with amyotrophic lateral sclerosis. Neuroepidemiology. 2008; 30:180-90. Epub 2008/04/19.
5. Kasarskis E J, Dempsey-Hall L, Thompson M M, Luu L C, Mendiondo M, Kryscio R. Rating the severity of ALS by caregivers over the telephone using the ALSFRS-R. Amyotroph Lateral Scler Other Motor Neuron Disord. 2005; 6:50-4. Epub 2005/07/23.
6. Pastula D M, Coffman C J, Allen K D, Oddone E Z, Kasarskis EJ, Lindquist JH, et al. Factors associated with survival in the National Registry of Veterans with ALS. Amyotroph Lateral Scler. 2009; 10:332-8. Epub 2009/11/20.
7. Brooks B R. E l Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial ' Clinical limits of amyotrophic lateral sclerosis ' workshop contributors. J Neurol Sci. 1994; 124 (Suppl):96-107. Epub 1994/07/01.
8. Brooks BR, Miller RG, Swash M, Munsat T L. Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000; 1:293-9. Epub 2001/07/24.
9. Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999; 169:13-21. Epub 1999/12/14.
10. Wicks P, Massagli MP, Wolf C, Heywood J. M easuring function in advanced ALS: validation of ALSFRS-EX extension items. Eur J Neurol. 2009; 16:353-9. Epub 2009/04/15.
11. Vonsattel JP, del Amaya MP, Keller CE. T wenty-fi rst century brain banking. Processing brains for research: the Columbia University methods. Acta Neuropathol. 2008; 115:509-32. Epub 2007/11/07.
12. Ravid R, Ferrer I. B rain banks as key part of biochemical and molecular studies on cerebral cortex involvement in Parkinson's disease. FEBS J. 2012; 279:1167-76.
13. Beach T G, Sue LI, Walker DG, Roher A E, Lue L, Vedders L, et al. The Sun Health Research Institute Brain Donation Program: description and experience, 1987-2007. Cell Tissue Bank. 2008 ;9: 229-45.
14. Monoranu CM, Apfelbacher M, Grunblatt E, Puppe B, Alafuzoff I, Ferrer I, et al. pH measurement as quality control on human post mortem brain tissue: A Study of the BrainNet Europe Consortium. Neuropathol Appl Neurobiol. 2008. Epub 2008/12/06.
15. Stan AD, Ghose S, Gao X M, Roberts R C, Lewis-Amezcua K, Hatanpaa KJ, et al. Human post mortem tissue: what quality markers matter Brain Res. 2006; 1123:1-11. Epub 2006/10/19.
16. Brownell B, Oppenheimer DR, Hughes JT. The central nervous system in motor neuron disease. J Neurol Neurosurg Psychiatry. 1970; 33:338-57. Epub 1970/06/01.
17. Neumann M, Sampathu DM, Kwong LK, Truax A C, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006; 314:130-3. Epub 2006/10/07.
18. Mackenzie IR, Rademakers R, Neumann M. T DP-43 and FUS in amyotrophic lateral sclerosis and frontotem-poral dementia. Lancet Neurol. 2010; 9:995-1007. Epub 2010/09/25.
19. Fecto F, Siddique T. M aking connections: pathology and genetics link amyotrophic lateral sclerosis with frontotemporal lobe dementia. Journal of Molecular Neuroscience:MN. 2011; 45:663-75. Epub 2011/09/09.
20. Tomita H, Vawter MP, Walsh DM, Evans SJ, Choudary PV, Li J, et al. Effect of agonal and post mortem factors on gene expression profi le: quality control in microarray analyses of post mortem human brain. Biol Psychiatry. 2004; 55:346-52.
21. Durrenberger PF, Fernando S, Kashefi SN, Ferrer I, Hauw JJ, Seilhean D, et al. Effects of ante mortem and post mortem variables on human brain mRNA quality: a Brain-Net Europe study. Journal of Neuropathology and Experimental Neurology. 2010; 69:70-81.
22. McKee AC, Gavett B E, Stern R A, Nowinski C J, Cantu R C, Kowall NW, et al. TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. Journal of Neuropathology and Experimental Neurology. 2010; 69:918-29. Epub 2010/08/20.
23. Armon C, Kurland LT, O 'Brien PC, Mulder DW. A ntecedent medical diseases in patients with amyotrophic lateral sclerosis. A population based case-controlled study in Rochester, Minn, 1925 through 1987. Arch Neurol. 1991; 48:283-6. Epub 1991/03/01.
24. Huisman MH, de Jong SW, Verwijs MC, Schelhaas HJ, van der Kooi AJ, de Visser M, et al. Family history of neurodegenerative and vascular diseases in ALS: a population based study. Neurology. 2011; 77:1363-9. Epub 2011/09/24.
25. Magnus T, Beck M, Giess R, Puls I, Naumann M, Toyka KV. Disease progression in amyotrophic lateral sclerosis: predictors of survival. Muscle Nerve. 2002; 25:709-14. Epub 2002/05/08.
26. Testa D, Lovati R, Ferrarini M, Salmoiraghi F, Filippini G. Survival of 793 patients with amyotrophic lateral sclerosis diagnosed over a 28-year period. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004; 5:208-12. Epub 2005/04/01.
27. Eisen A, Schulzer M, MacNeil M, Pant B, Mak E. D uration of amyotrophic lateral sclerosis is age dependent. Muscle Nerve. 1993; 16:27-32. Epub 1993/01/01.
28. del Grande A, Conte A, Lattante S, Luigetti M, Marangi G, Zollino M, et al. D11Y SOD1 mutation and benign ALS: a consistent genotype-phenotype correlation. J Neurol Sci. 2011; 309:31-3. Epub 2011/08/16.
29. Syriani E, Morales M, Gamez J. The p.E22G mutation in the Cu/Zn superoxide dismutase gene predicts a long survival time: clinical and genetic characterization of a sevengeneration ALS1 Spanish pedigree. J Neurol Sci. 2009; 285:46-53. Epub 2009/06/16.
30. Nalini A, Thennarasu K, Gourie-Devi M, Shenoy S, Kulshreshtha D. Clinical characteristics and survival pattern of 1153 patients with amyotrophic lateral sclerosis: experience over 30 years from India. J Neurol Sci. 2008; 272:60-70. Epub 2008/06/14.
31. Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Samarelli V, et al. Predictors of long survival in amyotrophic lateral sclerosis: a population based study. J Neurol Sci. 2008; 268:28-32. Epub 2007/11/21.
32. Mateen FJ, Carone M, Sorenson EJ. P atients who survive fi ve years or more with ALS in Olmsted County, 1925-2004. J Neurol Neurosurg Psychiatry. 2010; 81:1144-6. Epub 2010/07/16.
33. Grohme K, Maravic MV, Gasser T, Borasio GD. A case of amyotrophic lateral sclerosis with a very slow progression over 44 years. Neuromuscular Disorders: NMD. 2001; 11:414-6. Epub 2001/05/23.
34. Turner M R, Parton M J, Shaw C E, Leigh P N, Al-Chalabi A. Prolonged survival in motor neuron disease: a descriptive study of the King's database 1990-2002. J Neurol Neurosurg Psychiatry. 2003; 74:995-7. Epub 2003/06/18.
35. Bird TD, Leverenz J B. A lpha-synuclein in motor neuron disease: an immunohistologic study. Acta Neuropathol. 2004; 107:169-75. Epub 2003/12/03.
36. McKee A C, Stein T D, Nowinski CJ, Stern RA, Daneshvar DH, Alvarez VE, et al. The spectrum of disease in chronic traumatic encephalopathy. Brain. 2013; 136:43-64.
37. Li J Z, Vawter M P, Walsh D M, Tomita H, Evans S J, Choudary PV, et al. Systematic changes in gene expression in post mortem human brains associated with tissue pH and terminal medical conditions. Hum Mol Genet. 2004; 13:609-16. Epub 2004/01/22.
38. Ervin J F, Heinzen E L, Cronin K D, Goldstein D, Szymanski MH, Burke JR, et al. Post mortem delay has mini mal effect on brain RNA integrity. Journal of Neuropathology and Experimental Neurology. 2007; 66:1093-9.
39. Kingsbury AE, Foster O J, Nisbet AP, Cairns N, Bray L, Eve DJ, et al. Tissue pH as an indicator of mRNA preservation in human post mortem brain. Brain Res Mol Brain Res. 1995; 28:311-8.
40. Weickert C S, Sheedy D, Rothmond D A, Dedova I, Fung S, Garrick T, et al. Selection of reference gene expression in a schizophrenia brain cohort. Aust N Z JPsychiatry. 2010; 44:59-70.
41. Tunbridge E M, Eastwood S L, Harrison P J. C hanged relative to what Housekeeping genes and normalization strategies in human brain gene expression studies. Biol Psychiatry. 2011; 69:173-9.